In a HealthDay Now interview, Mabel Jong heard from experts with inside knowledge on the FDA’s controversial approval of aducanumab. First up is Dr. G. Caleb Alexander, a professor at Johns Hopkins who served on the FDA advisory committee that nearly unanimously advised against approving Biogen’s controversial new Alzheimer’s drug. Then, a conversation between Dr. Anton Porsteinsson, a principal investigator for the drug trial, and Dr. Ken Lin, a primary care physician who, like most clinicians surveyed in a new poll, has his concerns and has said he will not prescribe the new drug.Continue Reading

As the American Diabetes Association celebrated the 100th anniversary of the discovery of insulin, HealthDay spoke to to Dr. Robert Gabbay, chief scientific and medical officer of the group. Dr. Gabbay shared his thoughts on how to make insulin affordable and accessible to everyone who needs it. Continue Reading

As the American Diabetes Association concluded its annual meeting, HealthDay spoke to Dr. Robert Gabbay, the ADA’s chief scientific and medical officer. Dr. Gabbay shared highlights from the conference and discussed how the pandemic affected people with diabetes.Continue Reading

Two world-renowned medical groups — the European Hematology Association (EHA) and the International Conference on Malignant Lymphoma (ICML) — conducted virtual meetings this month to share advances in the care of blood-based cancers. In an interview with HealthDay’s Mabel Jong, Dr. Joshua Richter, assistant professor of medicine at the Tisch Cancer Institute, gave insights on the EHA meeting. Then, Dr. Anastasios Stathis, an oncologist and a member of this year’s ICML organizing committee, joined us to discuss ICML. Continue Reading

As the American College of Physicians kicked off its annual meeting, HealthDay Now’s Mabel Jong spoke to Dr. Jacqueline Fincher, president of the ACP and an internist in a rural community in Georgia. Dr. Fincher discussed the alarming shortage of primary care physicians, bringing basic health delivery needs to rural residents and why the ACP will focus on privacy concerns at its conference. Continue Reading